AngioDynamics Inc
NASDAQ:ANGO
AngioDynamics Inc
Accounts Receivables
AngioDynamics Inc
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
AngioDynamics Inc
NASDAQ:ANGO
|
Accounts Receivables
$43.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-3%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Accounts Receivables
$2.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
10%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Accounts Receivables
$2.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Stryker Corp
NYSE:SYK
|
Accounts Receivables
$4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Accounts Receivables
$6.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accounts Receivables
$1.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
AngioDynamics Inc
Glance View
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 800 full-time employees. The company went IPO on 2004-05-27. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.
See Also
What is AngioDynamics Inc's Accounts Receivables?
Accounts Receivables
43.2m
USD
Based on the financial report for Nov 30, 2024, AngioDynamics Inc's Accounts Receivables amounts to 43.2m USD.
What is AngioDynamics Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
-3%
Over the last year, the Accounts Receivables growth was -16%. The average annual Accounts Receivables growth rates for AngioDynamics Inc have been 4% over the past three years , 5% over the past five years , and -3% over the past ten years .
You don't have any saved screeners yet